Related Experiment Video
Updated: Jun 25, 2026
09:24
Isolation and Expansion of Human Glioblastoma Multiforme Tumor Cells Using the Neurosphere Assay
Published on: October 30, 2011
Glioblastoma in multiple sclerosis: a case report.
Giovanni Frisullo1, Agata Katia Patanella, Viviana Nociti
1Department of Neuroscience, Institute of Neurology, Catholic University, Largo Agostino Gemelli, 8, Rome 00168, Italy.
Journal of Neuro-Oncology
|February 14, 2009
Summary
T-bet, pSTAT1, and pSTAT3 expression in peripheral blood mononuclear cells (PBMCs) may help distinguish multiple sclerosis (MS) relapses from noninflammatory diseases like glioblastoma.
Area of Science:
- Neuroimmunology
- Oncology
Background:
- Multiple sclerosis (MS) relapses and cerebral tumors can present with similar clinical and MRI findings.
- Previous research indicated elevated T-bet, pSTAT1, and pSTAT3 in relapsing MS patients' mononuclear cells.
Observation:
- A relapsing-remitting MS patient with new neurological signs due to glioblastoma multiforme did not show increased T-bet, pSTAT1, and pSTAT3 expression in peripheral blood mononuclear cells (PBMCs).
Findings:
- The patient's condition suggests that T-bet, pSTAT1, and pSTAT3 expression levels in PBMCs may differ between MS relapses and noninflammatory neurological conditions.
- This observation highlights potential biomarkers for differential diagnosis.
Implications:
- T-bet, pSTAT1, and pSTAT3 expression in PBMCs could serve as a valuable tool to differentiate MS relapses from other diseases with overlapping symptoms.
- This may improve diagnostic accuracy and patient management in neurology and neuro-oncology.
